Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism.
AUTOR(ES)
Shortridge, V D
RESUMO
The molecular typing of 81 pretreatment Helicobacter pylori isolates and the comparison of 18 pretreatment-posttreatment pairs is described by restriction fragment length polymorphism (RFLP) of the ureC gene. The results of our study show the extreme genomic diversity of H. pylori and indicate that infection by H. pylori in the United States does not appear to be limited to a small number of RFLP types.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=229602Documentos Relacionados
- Molecular Typing of Helicobacter pylori Isolates from a Multicenter U.S. Clinical Trial by ureC Restriction Fragment Length Polymorphism
- PCR-based restriction fragment length polymorphism typing of Helicobacter pylori.
- Categorization of clinical isolates of Helicobacter pylori on the basis of restriction digest analyses of polymerase chain reaction-amplified ureC genes.
- The Helicobacter pylori ureC gene codes for a phosphoglucosamine mutase.
- Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism.
